Drug Profile
Research programme: cancer therapeutics - Novonco
Alternative Names: Epigenetics modulators - Novonco Therapeutics; Kinase inhibitors - Novonco TherapeuticsLatest Information Update: 28 Sep 2018
Price :
$50
*
At a glance
- Originator Novonco Therapeutics
- Class Small molecules
- Mechanism of Action Gene expression modulators; Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute myeloid leukaemia; Ovarian cancer; Pancreatic cancer
Most Recent Events
- 28 Sep 2018 No recent reports of development identified for research development in Acute-myeloid-leukaemia in USA
- 28 Sep 2018 No recent reports of development identified for research development in Ovarian-cancer in USA
- 28 Sep 2018 No recent reports of development identified for research development in Pancreatic-cancer in USA